Acuta Capital Partners, LLC Karuna Therapeutics, Inc. Transaction History

Acuta Capital Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$95.46 - $133.08 $477,299 - $665,400	-5,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$75.23 - $109.23 $639,455 - $928,455	-8,500 Reduced 62.96%	5,000 $508,000
Q3 2020 Nov 16, 2020	SELL	$71.31 - $109.74 $4.6 Million - $7.08 Million	-64,500 Reduced 82.69%	13,500 $1.04 Million
Q2 2020 Aug 14, 2020	BUY	$62.14 - $117.21 $1.37 Million - $2.58 Million	22,000 Added 39.29%	78,000 $8.69 Million
Q4 2019 Feb 14, 2020	BUY	$11.44 - $123.99 $640,640 - $6.94 Million	56,000 New	56,000 $4.22 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.